InMode Takes Legal Action Against Counterfeit Sales
InMode Ltd. (NASDAQ: INMD), a prominent name in medical technology, has successfully secured a preliminary injunction from the U.S. District Court, aimed at safeguarding its renowned Morpheus8 radiofrequency devices and related accessories from counterfeit sales. This decision marks a significant victory in InMode's fight against unlawful sellers who exploit its brand for their gain.
Understanding the Preliminary Injunction
The preliminary injunction was granted following a lawsuit initiated by InMode against several sellers identified as peddling counterfeit Morpheus8 products. The Honorable Michael Fitzgerald underscored the necessity of this legal measure in his ruling, reflecting that it serves the broader public interest. Notably, the court recognized that the sale of counterfeit devices poses substantial risks to patients who may unknowingly receive inferior or potentially harmful treatments.
The Impact of Counterfeit Medical Devices
The counterfeit market has increasingly become a concern in the medical device industry. Products like Morpheus8, designed for precise medical treatments, have seen imitation versions making their way to unsuspecting consumers. These counterfeit devices not only lack quality assurance but can also lead to severe health repercussions for individuals receiving treatment. InMode's decisive action aims to reassure patients and medical providers of the safety and efficacy of their products.
Corporate Commitment to Public Safety
InMode's commitment to public safety was strongly reiterated by CEO Moshe Mizrahy. He emphasized, "InMode has zero tolerance for dishonest business practices and considers the safety of the public its number one priority." This statement not only illustrates the company's ethical stance but also highlights its determination to combat counterfeit sales vigorously and ensure that only safe, effective products reach providers and patients.
Steps Towards Enforcement
InMode is prepared to employ all necessary strategies to enforce its trademarks and vigorously contest those who attempt to undermine its brand integrity. This includes collaborating with online platforms to identify and eliminate listings of counterfeit products. By prioritizing the protection of its assets, InMode reaffirms its mission of delivering high-quality medical solutions.
Patient Safety First
Patients in the United States seeking authentic Morpheus8 treatments can easily confirm their provider's authenticity through InMode’s official website. This proactive step allows consumers to ensure they are receiving genuine products from trusted providers, crucial for their health and recovery processes.
About InMode
InMode stands out as a leader in the innovative medical technology landscape. Specializing in the development and manufacturing of devices utilizing advanced radiofrequency (RF) technology, InMode aims to innovate surgical procedures and enhance existing treatment methods across various medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. The company is committed to delivering a broad array of effective medical solutions that prioritize patient safety and treatment efficacy.
Frequently Asked Questions
What action did InMode take against counterfeit sellers?
InMode obtained a preliminary injunction from the court to stop unauthorized sellers from distributing counterfeit Morpheus8 products.
Why is the injunction significant?
The injunction is critical for protecting public health, ensuring that only safe, genuine medical devices are available to patients.
How does InMode plan to enforce this ruling?
InMode aims to collaborate with online platforms to identify and remove counterfeit listings, ensuring brand integrity.
What should patients do to ensure they receive genuine Morpheus8 treatments?
Patients should verify their providers through InMode’s official website to ensure they receive authentic devices.
What is the focus of InMode’s technology?
InMode focuses on creating innovative medical technologies that enhance surgical procedures and improve patient outcomes across various specialties.
